Global Prefilled Syringes Market was valued at US$ 1,432.2 million in 2020 and is anticipated to reach US$ 3,301.1 million by 2027 displaying an elevated CAGR of 10% over the forecast period ...

with management highlighting differentiated profiles for MariTide and Repatha as mitigating factors. Amgen’s Q1 2025 earnings call highlighted strong revenue and volume growth, driven by key ...

Amgen’s first-quarter results were strong as it beat estimates for both earnings as well as sales. Sales of most of its products, Prolia, Xgeva, Repatha, Blincyto and Evenity beat estimates.

Deep-pocketed investors have adopted a bearish approach towards Amgen AMGN, and it's something ... Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung ...

Amgen AMGN reported first-quarter 2025 adjusted ... of $406.0 million as well as our model estimate of $370.0 million. Repatha generated revenues of $656.0 million, up 27% year over year, driven ...

Amgen Inc (NASDAQ:AMGN) launched three new products or indications and initiated four new Phase 3 studies, demonstrating robust pipeline progress. Repatha sales increased by 27% year over year ...

Fourteen products delivered at least double-digit sales growth in the quarter, including Repatha, BLINCYTO, and TEZSPIRE. The company’s newly launched IMDELLTRA generated $81 million in sales. For the ...

THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first ...

Amgen Inc. reported better-than-expected earnings for the first quarter of 2025, with earnings per share (EPS) of $4.90 surpassing the forecast of $4.29. The company also exceeded revenue expectations ...

Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options ... Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer ...

In early April, the company reported that the FDA had approved a prefilled syringe version of Vyvgart Hytrulo that will allow patients to administer the drug themselves at their homes. Meanwhile ...